Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of a Stannous Fluoride Toothpaste for Dentin Hypersensitivity in a Chinese Population
NCT07352956Completed
- Sponsor
- Haleon
- Start
- Jan 2026
- Primary completion
- Apr 2026
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Randomised, single-blind trial of stannous fluoride in dentin hypersensitivity (DH) (2 arms), sponsored by Haleon. Primary endpoints: Schiff Sensitivity Score at Day 56 and Tactile Threshold at Day 56. Started Jan 2026; status: completed.
02
Drugs
stannous fluoride
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT07352956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07352956.